SMARCB1 and cancer: SWI/SNF chromatin remodellers were first linked to cancer development more than two decades ago when it was discovered that biallelic loss-of-function mutations of the SMARCB1 gene drive tumourigenesis in malignant rhabdoid tumours (MRTs) [26].